Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Taxotere Breast Cancer Drug Lawsuit Filed Over Permanent Hair Loss June 23, 2016 Irvin Jackson Add Your Comments The makers of the breast cancer drug Taxotere face a growing number of hair loss lawsuits filed on behalf of women nationwide, who allege they were not adequately warned that hair may not regrow following chemotherapy, and that equally effective alternative treatments were available that do not carry the same risk. One of the latest lawsuits was filed by Carol Webb, of Gretna, Louisiana, who filed her complaint (PDF) in the U.S. District Court for the Eastern District of Louisiana on June 17. Like other lawsuits over hair loss from Taxotere, Webb alleges that Sanofi-Aventis knew or should have known about the risk when they introduced the high-potency taxane-based drug, yet failed to adequately warn women and the medical community, while promoting use of their newer medication, even though it is no more effective than older breast cancer treatments that were already on the market. Learn More About Taxotere Lawsuits Side effects of Taxotere may cause sudden eye problems or result in permanent hair loss. Lawsuits reviewed nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Taxotere Lawsuits Side effects of Taxotere may cause sudden eye problems or result in permanent hair loss. Lawsuits reviewed nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Webb indicates that she was diagnosed with infiltrating ductal carcinoma of the right breast in January 2010, and began chemotherapy treatment that included Taxotere in September 2010. Following the use of the breast cancer drug, Webb indicates that her hair has never regrown, leaving her with a permanent and disfiguring condition known as permanent alopecia. The lawsuit notes that the manufacturers failed to disclose information about the link between Taxotere and permanent hair loss, providing false and misleading information that suggested hair would regrow following use of the breast cancer drug. Webb points to research available as early as 2005, including a study known as GEICAM 9805, which found that nearly one out of every 10 patients treated with Taxotere suffered hair loss that lasted up to 10 years and five months following chemotherapy, and in some cases longer. Webb also points out that Taxotere carries warnings about the risk of permanent hair loss in some other countries, but those same warnings are not provided to consumers or doctors in the United States. “Despite the fact that Defendants disclosed risks associated with Taxotere and permanent alopecia to patients and regulatory agencies in other countries, Defendants failed to either alert Plaintiff, the public, and the scientific community in the United States or perform further investigation into the safety of Taxotere regarding the side effect of disfiguring permanent alopecia,” the lawsuit states. “Defendants failed to update the warnings for Taxotere, and they failed to disclose the results of additional studies as Defendants learned new facts regarding the defects and risks of their product.” Webb’s complaint and other lawsuits point out that while women may have accepted the Taxotere risk of permanent hair loss if no other treatment options were available, this was not the case, as similar drugs on the market at the time Taxotere was introduced provided the same treatment benefits without subjecting female users to the same risk of permanent hair loss. Webb presents claims of defective design, inadequate warning, and breach of warranty. Tags: Alopecia, Breast Cancer, Chemotherapy, Hair Loss, Sanofi-Aventis, Taxotere Image Credit: | More Taxotere Lawsuit Stories Taxotere Epiphora Lawsuit Filed Over Excessively Watery Eyes March 24, 2023 Lack of Taxotere Warnings Over Blocked Tear Ducts Justify Lawsuits Moving Forward August 2, 2022 Motion Filed to Dismiss Taxotere Lawsuits Over Excessive Tearing Problems July 7, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: today) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025) Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: today) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025) Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: yesterday) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: today) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: today) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)
Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: yesterday) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)